Subscribe To
IKNA / Ikena Oncology, Inc. (IKNA) Stock Jumps 7.9%: Will It Continue to Soar?
IKNA News
By Zacks Investment Research
June 20, 2023
Recent Price Trend in Ikena Oncology, Inc. (IKNA) is Your Friend, Here's Why
Ikena Oncology, Inc. (IKNA) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the more_horizontal
By Zacks Investment Research
June 2, 2023
Ikena Oncology, Inc. (IKNA) Is a Great Choice for 'Trend' Investors, Here's Why
Ikena Oncology, Inc. (IKNA) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the more_horizontal
By Zacks Investment Research
May 5, 2023
Ikena Oncology, Inc. (IKNA) Stock Jumps 7.9%: Will It Continue to Soar?
Ikena Oncology, Inc. (IKNA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisi more_horizontal
By Zacks Investment Research
March 14, 2023
Ikena Oncology, Inc. (IKNA) Reports Q4 Loss, Tops Revenue Estimates
Ikena Oncology, Inc. (IKNA) delivered earnings and revenue surprises of 26.42% and 67.02%, respectively, for the quarter ended December 2022. Do the n more_horizontal
By GlobeNewsWire
March 7, 2022
Ikena Oncology to Present Preclinical Findings on IK-930, a Novel TEAD Inhibitor at the 2022 American Association for Cancer Research (AACR) Annual Meeting
BOSTON, March 07, 2022 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA), a targeted oncology company navigating new territory in patient-direct more_horizontal